HighTower Advisors’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-200
Closed -$515K 3534
2022
Q4
$515K Buy
200
+199
+19,900% +$105K ﹤0.01% 2114
2022
Q3
$5K Buy
+1
New +$486 ﹤0.01% 3055
2021
Q1
Sell
-295
Closed -$304K 3150
2020
Q4
$304K Buy
+295
New +$123K ﹤0.01% 1918

Other funds holding HUM

HighTower Advisors's HUM Position: Q1 2026 in Review

HighTower Advisors reduced its Humana (HUM) stake by 22% in Q1 2026, selling an estimated $314K and leaving 5,486 shares worth $951K. The position accounts for ﹤0.01% of the portfolio, ranked #2220.

HighTower Advisors first reported a position in HUM in Q3 2014 and has held it in 47 quarters since. The position peaked at $8.52M in Q3 2023. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • HighTower Advisors held 5,486 shares of Humana worth $951K as of Q1 2026.
  • HighTower Advisors sold 1,533 Humana shares in Q1 2026, an estimated $314K.
  • Humana made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #2220 holding.
  • HighTower Advisors first reported a position in Humana in Q3 2014 and has held it in 47 quarters since.
  • HighTower Advisors's Humana position peaked at $8.52M in Q3 2023.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.